Vivos Therapeutics (VVOS) Return on Sales (2020 - 2026)

Vivos Therapeutics (VVOS) has 7 years of Return on Sales data on file, last reported at 0.02% in Q1 2026.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (down 1.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
• Return on Sales grew to 0.02% in Q1 2026 per VVOS's latest filing, from 0.02% in the prior quarter.
• Across five years, Return on Sales topped out at 0.03% in Q4 2023 and bottomed at 0.02% in Q4 2025.
• The 5-year median for Return on Sales is 0.01% (2022), against an average of 0.01%.
• The widest annual swing landed in 2023, when Return on Sales advanced 4 bps; it then fell 4 bps in 2024.
• Tracing VVOS's Return on Sales over 5 years: stood at 0.02% in 2022, then soared by 287 bps to 0.03% in 2023, then slumped by 127 bps to 0.01% in 2024, then sank by 133 bps to 0.02% in 2025, then advanced by 17 bps to 0.02% in 2026.
• Per Business Quant, the three latest VVOS Return on Sales figures stand at 0.02% (Q1 2026), 0.02% (Q4 2025), and 0.01% (Q3 2025).

Peer Comparison